Texas Instruments Incorporated (NASDAQ: TXN) heads into Monday’s U.S. session with investors still digesting October earnings, a fresh dividend, a governance shift, and significant manufacturing updates across the U.S. and Asia. TXN shares last closed at $159.33 on Friday, November 14, 2025.
Quick take
- Price & profile (as of last close): $159.33; market cap roughly $145B; 52‑week range $139.95–$221.69.
- Most recent results (Q3 FY2025):Revenue $4.74B, EPS $1.48; Q4 outlook: revenue $4.22–$4.58B, EPS $1.13–$1.39. Shares fell after the guide.
- Capital returns:Dividend lifted 4% to $1.42 per share (paid Nov. 12).
- Manufacturing footprint: TI plans to invest $60B+ in seven U.S. fabs; opened a second assembly & test factory in Melaka, Malaysia on Nov. 6.
- Governance: CEO Haviv Ilan will also become chairman effective January 2026 (succeeding Rich Templeton).
Where the stock stands
Friday’s close: TXN finished at $159.33 after a choppy week for semis. Trailing valuation on many services sits around the high‑20s P/E, with forward P/E in the mid‑20s; market cap totals about $145B. Use those multiples as context, not gospel, given differing data feeds and timing.
Range check: Over the last year, TXN has traded between $139.95 and $221.69, underscoring the sector’s sensitivity to inventory normalization and macro data.
The latest company news you should know
1) Q3 results and Q4 guide reset expectations
TI posted Q3 revenue of $4.74B and EPS of $1.48. Management guided Q4 revenue to $4.22–$4.58B and EPS to $1.13–$1.39, below Street consensus, which sparked a next‑day selloff. Multiple brokers trimmed targets following the outlook.
- Example moves: Mizuho downgraded TXN to Underperform and cut its target to $150; JPMorgan reduced its target but kept Overweight. These changes framed the post‑report debate on valuation versus near‑term growth.
2) Dividend growth continues
TI raised its quarterly dividend 4% to $1.42 (payable Nov. 12, 2025), marking the company’s 22nd consecutive annual increase—a key pillar of the “all FCF returned to owners over time” narrative. The board formally declared the payout on Oct. 16. Texas Instruments
3) Governance update
On Oct. 16, the board elected CEO Haviv Ilan as chairman effective January 2026, as long‑time chairman Rich Templeton retires at year‑end 2025. Investors will listen for any strategic nuances in Ilan’s Dec. 2 appearance at UBS.
4) Manufacturing expansion: U.S. and Malaysia
- U.S.: TI announced plans to invest more than $60 billion across seven U.S. fabs in Texas and Utah, a multi‑year bet on “foundational” (mature‑node) semiconductors. The Sherman (TX) megasite’s first new fab (SM1) remains slated to begin initial production in 2025. Reuters
- Malaysia: TI opened its second assembly & test factory in Melaka on Nov. 6, designed to assemble/test billions of chips annually and to lift internal A&T to 90% by 2030.
- Funding tailwind: TI finalized an award agreement for up to $1.6B in CHIPS Act funding (Dec. 2024), with additional investment tax credits expected, helping underwrite U.S. capacity adds.
5) Workforce reshaping as older lines close
Local reports indicate layoffs tied to the closure of legacy 150‑mm fabs in North Texas as TI transitions to 300‑mm production. The company has reiterated its long‑term commitment to the region alongside new fabs.
Sector & macro angles that matter Monday
- China trade overhang: In mid‑September, China’s Ministry of Commerce launched an anti‑dumping investigation into certain U.S. analog ICs (segments where TI is a key supplier). Any headlines here can swing analog names.
- Read‑through from peers:Analog Devices (ADI) reports Nov. 25 (pre‑market). Commentary on industrial/auto demand and channel inventories could color near‑term sentiment for TXN.
- Management visibility:CEO Haviv Ilan is scheduled to speak at the UBS Global Technology & AI Conference on Dec. 2; investors will look for updates on demand, CapEx cadence, and FCF path.
Key numbers & expectations
- Last close:$159.33 (Nov. 14, 2025).
- Consensus for the December quarter: Street EPS estimates center near $1.28, within TI’s official $1.13–$1.39 range.
- Market context: Reuters noted TXN’s shares fell ~8% the day after the Q4 outlook, with several brokers lowering targets—spotlighting a cautious stance on the analog recovery timeline.
What to watch at the open (17.11.2025)
- Any U.S.–China trade headlines tied to the anti‑dumping probe into U.S. analog chips. TXN’s exposure to “foundational” nodes makes it a focal point for policy‑driven swings. Reuters
- Peer moves ahead of ADI’s Nov. 25 earnings and any preview notes out of the sell‑side.
- Follow‑through from manufacturing news, including the Melaka ramp and continued progress at Sherman. Supply‑chain resilience and cost advantages from 300‑mm remain central to the long‑term story.
Bottom line
Heading into Monday, TXN sits at the intersection of inventory normalization, policy risk, and a massive capacity build‑out designed to strengthen long‑run cost and supply advantages. The Q4 guide reset keeps near‑term expectations conservative, but dividend growth, capital discipline, and U.S. manufacturing incentives cushion the long‑term thesis. Traders will key on China headlines and peer read‑throughs; long‑term holders will focus on utilization ramps, CapEx moderation into 2026, and free‑cash‑flow trajectory.
This article is for information only and is not investment advice. Markets can move quickly—always verify figures against your broker or data terminal before trading.
